Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) Short Interest Update

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) saw a large decrease in short interest in the month of June. As of June 30th, there was short interest totaling 65,513 shares, a decrease of 54.0% from the June 15th total of 142,536 shares. Based on an average daily volume of 1,245,678 shares, the days-to-cover ratio is currently 0.1 days. Approximately 0.0% of the company’s shares are sold short.

Wall Street Analyst Weigh In

CLPBY has been the topic of a number of analyst reports. The Goldman Sachs Group cut Coloplast A/S from a “hold” rating to a “strong sell” rating in a research note on Tuesday, April 7th. Kepler Capital Markets raised Coloplast A/S to a “strong-buy” rating in a research note on Wednesday, May 20th. One analyst has rated the stock with a Strong Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold”.

Coloplast A/S Trading Down 1.8%

CLPBY stock opened at $6.09 on Wednesday. Coloplast A/S has a 12 month low of $5.64 and a 12 month high of $10.03. The firm’s 50-day moving average is $6.08 and its 200 day moving average is $7.03. The company has a market capitalization of $13.72 billion, a PE ratio of 43.50, a P/E/G ratio of 1.96 and a beta of 0.22. The company has a debt-to-equity ratio of 1.66, a current ratio of 1.75 and a quick ratio of 1.09.

Coloplast A/S (OTCMKTS:CLPBY) last released its quarterly earnings data on Tuesday, May 12th. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.01. The company had revenue of $1.11 billion during the quarter, compared to analysts’ expectations of $1.11 billion. Coloplast A/S had a net margin of 7.46% and a return on equity of 33.15%. On average, research analysts anticipate that Coloplast A/S will post 0.38 EPS for the current year.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.